Reported Standalone quarterly numbers for Mangalam Drugs & Organics are:Net Sales at Rs 91.11 crore in March 2023 down 24.68% from Rs. 120.96 crore in March 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 4.39 crore in March 2023 down 165.54% from Rs. 6.69 crore in March 2022.
EBITDA stands at Rs. 0.54 crore in March 2023 down 94.71% from Rs. 10.20 crore in March 2022.
Mangalam Drugs shares closed at 107.25 on May 30, 2023 (NSE) and has given -23.47% returns over the last 6 months and -14.30% over the last 12 months.
| Mangalam Drugs & Organics | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 90.27 | 63.33 | 119.83 | | Other Operating Income | 0.84 | -- | 1.13 | | Total Income From Operations | 91.11 | 63.33 | 120.96 | | EXPENDITURE | | Consumption of Raw Materials | 55.03 | 67.01 | 75.11 | | Purchase of Traded Goods | 0.93 | 0.90 | 1.22 | | Increase/Decrease in Stocks | 14.97 | -35.78 | 7.67 | | Power & Fuel | -- | -- | -- | | Employees Cost | 6.29 | 9.43 | 11.62 | | Depreciation | 2.75 | 2.88 | 2.69 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 13.65 | 15.30 | 15.15 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -2.51 | 3.59 | 7.51 | | Other Income | 0.29 | 0.13 | -- | | P/L Before Int., Excpt. Items & Tax | -2.21 | 3.72 | 7.51 | | Interest | 3.43 | 3.22 | 2.53 | | P/L Before Exceptional Items & Tax | -5.65 | 0.50 | 4.98 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -5.65 | 0.50 | 4.98 | | Tax | -1.26 | 0.08 | -1.71 | | P/L After Tax from Ordinary Activities | -4.39 | 0.43 | 6.69 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -4.39 | 0.43 | 6.69 | | Equity Share Capital | 15.83 | 15.83 | 15.83 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.77 | 0.27 | 4.23 | | Diluted EPS | -2.77 | 0.27 | 4.23 | | EPS After Extra Ordinary | | Basic EPS | -2.77 | 0.27 | 4.23 | | Diluted EPS | -2.77 | 0.27 | 4.23 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
